Trial news

We have now reached and exceeded our target for Analysis Stage 1 (AS1) with 384 participants randomised! Many thanks to all the site staff participating in Octopus, everyone who has been screened and randomised and all those who are signed on to join Octopus as we move into Analysis Stage 2 (AS2)! Check out the table below to see how we have done now that AS1 has ended: ...

One of Octopus' Personal and Public Involvement representatives, Susan Scott, recently was featured in an episode of MS Society's Research dates. She discussed clinical trials; their hopes for the future of MS care; the Octopus trial and importance of patient involvement in trials like Octopus. You can watch the video below and check out more of MS Society's MS Research dates ...

We have now reached 382 participants randomised and 441 participants screened meaning we have recruited 110% of our goal for analysis stage 1 (375). We have not only reached our goal but exceeded it!! Many thanks to all the site staff participating in Octopus, everyone who has been screened and randomised and all those who are signed on to join Octopus as we move into Stage ...

We have created an FAQ and Participant Information Sheet video, to help supplement the current FAQs and Participant Information Sheet available on the website!

Cardiff Biobank closure 28th Oct -1st November, and will be unable to unable to receive samples during this time.